Skip to main content
TipRanks
Go Ultimate75% OFF

Robert J. Israel Insider Profile

4 Followers

Robert J. Israel, former Executive Vice President, Medi at Progenics, holds 35.05K shares in Progenics (Ticker: PGNX).

Robert J. Israel's Trading History

PGNX
Progenics
Jun 12, 2015―Uninformative Sell13.66K$143.71K
PGNX
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 12, 2015Uninformative Sell$13.66K2,000$6.83―
Mar 16, 2015Uninformative Sell$21.00K3,000$7.00―
Mar 12, 2015Uninformative Sell$13.66K2,000$6.83―
Mar 04, 2015Uninformative Sell$32.45K5,000$6.49―
Jan 13, 2015Uninformative Sell$14.10K2,000$7.05―

You May Also Like

Robert J. Israel insider profile FAQ

What is the percentage of profitable transactions made by Robert J. Israel?
The percentage of profitable transactions made by Robert J. Israel is 50%.
What is the average return per transaction made by Robert J. Israel?
The average return per transaction made by Robert J. Israel is -2.80%.
What stocks does Robert J. Israel hold?
Robert J. Israel holds: PGNX stocks.
What was Robert J. Israel’s latest transaction?
Robert J. Israel’s latest transaction was an Uninformative Sell of $13.66K.
What was Robert J. Israel's most profitable transaction?
Robert J. Israel’s most profitable transaction was an Informative Sell of PGNX stock on September 21, 2011. The return on the trade was 40.80%.
What is Robert J. Israel's role in Progenics?
Robert J. Israel's role in Progenics is Executive Vice President, Medi.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.